Vaarunya Biolabs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.11 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.22 Cr
- Revenue Growth 109.40%
- Profit Growth 530.42%
- Ebitda 41.64%
- Net Worth 47.04%
- Total Assets 29.86%
About Vaarunya Biolabs
Vaarunya Biolabs Private Limited (VBPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 2018 (Six years and three months 20 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹1.22 Cr.
Suhas and Suresh Radhakrishnamurthy serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999KA2018PTC117607
-
Company No.
117607
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Oct 2018
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Vaarunya Biolabs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suhas
|
Director | 15-Oct-2018 | Current |
|
Suresh Radhakrishnamurthy
|
Director | 15-Oct-2018 | Current |
Financial Performance of Vaarunya Biolabs.
Vaarunya Biolabs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 109.4% increase. The company also saw a substantial improvement in profitability, with a 530.42% increase in profit. The company's net worth Soared by an impressive increase of 47.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaarunya Biolabs?
In 2022, Vaarunya Biolabs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹12.20 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 1.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Sep 2019 | Bank Of India | ₹1.22 Cr | Open |
How Many Employees Work at Vaarunya Biolabs?
Unlock and access historical data on people associated with Vaarunya Biolabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaarunya Biolabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaarunya Biolabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.